Tesla is building mobile molecule printers to help make the potential COVID-19 vaccine being developed by German company CureVac, the electric carmaker's CEO Elon Musk tweeted on Thursday. CureVac is developing portable and automated mRNA production units it calls printers, which Musk described as "RNA microfactories". They are being designed to be shipped to remote locations.